Seven Eight Capital’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-14,415
Closed -$1.26M 620
2019
Q4
$1.26M Sell
14,415
-900
-6% -$78.7K 0.07% 417
2019
Q3
$1.3M Buy
+15,315
New +$1.36M 0.07% 382
2019
Q1
Sell
-9,400
Closed -$787K 670
2018
Q4
$787K Buy
+9,400
New +$851K 0.04% 376
2018
Q1
Sell
-4,900
Closed -$345K 485
2017
Q4
$345K Buy
+4,900
New +$354K 0.04% 370
2016
Q3
Sell
-1,400
Closed -$48K 477
2016
Q2
$48K Buy
+1,400
New +$43.7K 0.02% 454

Other funds holding NGVT

Seven Eight Capital's NGVT Position: Q1 2020 in Review

Seven Eight Capital sold out of Ingevity (NGVT) in Q1 2020, closing a stake of 14,415 shares — an estimated $1.26M sold.

Seven Eight Capital first reported a position in NGVT in Q2 2016 and held it in 5 quarters. The position peaked at $1.3M in Q3 2019. 272 funds tracked by Wall St. Rank hold NGVT as of Q1 2020.

  • Seven Eight Capital reported no remaining Ingevity position as of Q1 2020 after selling out during the quarter.
  • Seven Eight Capital sold 14,415 Ingevity shares in Q1 2020, an estimated $1.26M.
  • Seven Eight Capital first reported a position in Ingevity in Q2 2016 and held it in 5 quarters.
  • Seven Eight Capital's Ingevity position peaked at $1.3M in Q3 2019.
  • 272 funds tracked by Wall St. Rank held Ingevity as of Q1 2020.

Based on Seven Eight Capital's 13F filing for Q1 2020, filed 14 May 2020.